Factors affecting early attrition and later treatment course of antidepressant treatment of depression in naturalistic settings: An 18-month nationwide population-based study

Journal of Psychiatric Research

Volumn 47, Issue 7, 2013, Pages 916-925

  Pan, Yi Ju ^a,b,e   Liu, Shi Kai ^b,c   Yeh, Ling Ling ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d ASIA UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antidepressant treatment; Attrition; Depression; Patient physician communication; Treatment course

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACKACHE; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; DEMOGRAPHY; DEPRESSION; EARLY TREATMENT ATTRITION; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SYMPTOM; TAIWAN; TREATMENT OUTCOME;

EID: 84877154108     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.03.005     Document Type: Article

References (40)

1. Aalten P., de Vugt M.E., Jaspers N., Jolles J., Verhey F.R. The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. International Journal of Geriatric Psychiatry 2005, 20:523-530.
2. Aikens J.E., Klinkman M.S. Changes in patients' beliefs about their antidepressant during the acute phase of depression treatment. General Hospital Psychiatry 2012, 34:221-226.
3. Arnow B.A., Blasey C., Manber R., Constantino M.J., Markowitz J.C., Klein D.N., et al. Dropouts versus completers among chronically depressed outpatients. Journal of Affective Disorders 2007, 97:197-202.
4. Arroll B., Elley C.R., Fishman T., Goodyear-Smith F.A., Kenealy T., Blashki G., et al. Antidepressants versus placebo for depression in primary care. Cochrane Database of Systematic Reviews 2009, CD007954.
5. Bair M.J., Robinson R.L., Katon W., Kroenke K. Depression and pain comorbidity: a literature review. Archives of Internal Medicine 2003, 163:2433-2445.
6. Bergh S., Engedal K., Roen I., Selbaek G. The course of neuropsychiatric symptoms in patients with dementia in Norwegian nursing homes. International Psychogeriatrics 2011, 23:1231-1239.
7. Bull S.A., Hu X.H., Hunkeler E.M., Lee J.Y., Ming E.E., Markson L.E., et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002, 288:1403-1409.
8. Demyttenaere K., Adelin A., Patrick M., Walthere D., Katrien de B., Michele S. Six-month compliance with antidepressant medication in the treatment of majordepressive disorder. International Clinical Psychopharmacology 2008, 23:36-42.
9. Dunlop B.W., Kelley M.E., Mletzko T.C., Velasquez C.M., Craighead W.E., Mayberg H.S. Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. Journal of Psychiatric Research 2012, 46:375-381.
10. Fava M., Mallinckrodt C.H., Detke M.J., Watkin J.G., Wohlreich M.M. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?. Journal of Clinical Psychiatry 2004, 65:521-530.
11. Gameroff M.J., Olfson M. Major depressive disorder, somatic pain, and health care costs in an urban primary care practice. Journal of Clinical Psychiatry 2006, 67:1232-1239.
12. Gasto C., Navarro V., Catalan R., Portella M.J., Marcos T. Residual symptoms in elderly major depression remitters. Acta Psychiatrica Scandinavica 2003, 108:15-19.
13. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001, 286:2578-2585.
14. Hunot V.M., Horne R., Leese M.N., Churchill R.C. Acohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Primary Care Companion to the Journal of Clinical Psychiatry 2007, 9:91-99.
15. Husain M.M., Rush A.J., Trivedi M.H., McClintock S.M., Wisniewski S.R., Davis L., et al. Pain in depression: STAR*D study findings. Journal of Psychosomatic Research 2007, 63:113-122.
16. Israel J.A. The impact of residual symptoms in major depression. Pharmaceuticals 2010, 3:2426-2440.
17. Joosten E.A., DeFuentes-Merillas L., de Weert G.H., Sensky T., van der Staak C.P., de Jong C.A. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychotherapy and Psychosomatics 2008, 77:219-226.
18. Judd L.L., Akiskal H.S., Maser J.D., Zeller P.J., Endicott J., Coryell W., et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders 1998, 50:97-108.
19. Katon W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry 2003, 54:216-226.
20. Kennedy N., Abbott R., Paykel E.S. Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort. Psychological Medicine 2003, 33:827-838.
21. van der Lem R., van der Wee N.J., van Veen T., Zitman F.G. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice. Psychotherapy and Psychosomatics 2012, 81:226-234.
22. Leuchter A.F., Husain M.M., Cook I.A., Trivedi M.H., Wisniewski S.R., Gilmer W.S., et al. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) report. Psychological Medicine 2010, 40:239-251.
23. Lin E.H., Von Korff M., Katon W., Bush T., Simon G.E., Walker E., et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care 1995, 33:67-74.
24. Ludman E., Katon W., Bush T., Rutter C., Lin E., Simon G., et al. Behavioural factors associated with symptom outcomes in a primary care-based depression prevention intervention trial. Psychological Medicine 2003, 33:1061-1070.
25. Maddox J.C., Levi M., Thompson C. The compliance with antidepressants in general practice. Journal of Psychopharmacology 1994, 8:48-52.
26. Manber R., Chambers A.S., Hitt S.K., McGahuey C., Delgado P., Allen J.J. Patients' perception of their depressive illness. Journal of Psychiatric Research 2003, 37:335-343.
27. Nierenberg A.A., Keefe B.R., Leslie V.C., Alpert J.E., Pava J.A., Worthington J.J., et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. Journal of Clinical Psychiatry 1999, 60:221-225.
28. Ohayon M.M., Schatzberg A.F. Chronic pain and major depressive disorder in the general population. Journal of Psychiatric Research 2010, 44:454-461.
29. Pettit J.W., Lewinsohn P.M., Roberts R.E., Seeley J.R., Monteith L. The long-term course of depression: development of an empirical index and identification of early adult outcomes. Psychological Medicine 2009, 39:403-412.
30. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 2006, 163:1905-1917.
31. Savva G.M., Zaccai J., Matthews F.E., Davidson J.E., McKeith I., Brayne C. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry 2009, 194:212-219.
32. Sobocki P., Ekman M., Agren H., Runeson B., Jonsson B. The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression. International Journal of Clinical Practice 2006, 60:791-798.
33. Thase M.E., Simons A.D., McGeary J., Cahalane J.F., Hughes C., Harden T., et al. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. American Journal of Psychiatry 1992, 149:1046-1052.
34. Von Korff M., Katon W., Rutter C., Ludman E., Simon G., Lin E., et al. Effect on disability outcomes of a depression relapse prevention program. Psychosomatic Medicine 2003, 65:938-943.
35. Warden D., Rush A.J., Wisniewski S.R., Lesser I.M., Kornstein S.G., Balasubramani G.K., et al. What predicts attrition in second step medication treatments for depression?: a STAR*D report. International Journal of Neuropsychopharmacology 2009, 12:459-473.
36. Warden D., Trivedi M.H., Wisniewski S.R., Davis L., Nierenberg A.A., Gaynes B.N., et al. Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. American Journal of Psychiatry 2007, 164:1189-1197.
37. Warden D., Trivedi M.H., Wisniewski S.R., Lesser I.M., Mitchell J., Balasubramani G.K., et al. Identifying risk for attrition during treatment for depression. Psychotherapy and Psychosomatics 2009, 78:372-379.
38. Weich S., Morgan L., King M., Nazareth I. Attitudes to depression and its treatment in primary care. Psychological Medicine 2007, 37:1239-1248.
39. Wetzels R.B., Zuidema S.U., de Jonghe J.F., Verhey F.R., Koopmans R.T. Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. American Journal of Geriatric Psychiatry 2010, 18:1054-1065.
40. WHO Adherence to long-term therapies: evidence for action. Noncommunicable disease and mental health adherence to long-term therapies project 2003, World Health Organization, Geneva.